Clark, NJ, United States of America

Yi Ning Ji Chen

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Ning Ji Chen. Retrieved from https://idiyas.com/inventor/yi-ning-ji-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 20.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yi Ning Ji Chen

Introduction

Yi Ning Ji Chen is an accomplished inventor based in Clark, NJ, known for his significant contributions to the field of pharmaceuticals. With a focus on developing compounds for the treatment of viral infections, he has made strides in the area of nucleoside phosphoramidate compounds.

Latest Patents

Yi Ning Ji Chen holds a patent for a process for making chloro-substituted nucleoside phosphoramidate compounds. This invention is particularly relevant for the treatment and prophylaxis of HCV infection. The patent outlines a method for synthesizing these compounds, which are also useful as synthetic intermediates in the production of related pharmaceutical agents.

Career Highlights

Currently, Yi Ning Ji Chen is employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to contribute to innovative solutions in the pharmaceutical industry, particularly in the development of antiviral therapies.

Collaborations

Throughout his career, Yi Ning Ji Chen has collaborated with notable colleagues, including John Y L Chung and Amude Kassim. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Yi Ning Ji Chen's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the development of antiviral compounds, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…